Effective August 15, Blueprint Genetics will transition laboratory services to our global headquarters and laboratory in Helsinki, Finland and discontinue providing lab services from the US. For more information, please visit https://blueprintgenetics.com/us-lab-operations/.
If you are having trouble viewing the webinar video, please try clearing your browser’s cookies/cache.
This educational webinar on genetic diagnostics and targeted therapies of Primary Immunodeficiency Diseases (PID) is led by Dr Jolan E. Walter. The current understanding of the genetic basis of PID and the present and emerging reasons for offering genetic diagnostics for these patients are discussed. A focus is placed on the challenges involved with next generation sequencing (NGS) and considerations that should be made when selecting optimal testing for patients.
Last modified: June 04, 2024
Watch the webinar
Note: due to a temporary technical limitation our webinar signup/access form below does not load in some browsers if cookies have not been allowed. If you do not see the form below, please allow cookies by clicking here to open the cookie preference centre, then allow cookies and reload this page. You can disallow cookies once you have signed up if you wish.
Note: due to a temporary technical limitation the newsletter subscription form below does not load in some browsers if cookies have not been allowed. If you do not see the form below, please allow cookies by clicking here to open the cookie preference centre, then allow cookies and reload this page. You can disallow cookies once you have signed up if you wish.
Please be advised that a specimen collection kit must be requested by a medical professional.
If you are a patient or family member of a patient, please contact your provider to place a kit order on your behalf.